Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer

被引：0
|
作者：
Govindan, R. [1 ]
Fakih, M. [2 ]
Price, T. [3 ]
Falchook, G. [4 ]
Desai, J. [5 ]
Kuo, J. [6 ]
Strickler, J. [7 ]
Krauss, J. [8 ]
Li, B. [9 ]
Denlinger, C. [10 ]
Durm, G. [11 ]
Ngang, J. [12 ]
Henary, H. [12 ]
Ngarmchamnanrith, G. [12 ]
Rasmussen, E. [12 ]
Morrow, P. K. [12 ]
Hong, D. [13 ]
机构：
[1] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA
[2] City Hope Natl Med Ctr, Duarte, CA USA
[3] Queen Elizabeth Hosp, Woodville South, Australia
[4] HealthONE, Sarah Cannon Res Inst, Denver, CO USA
[5] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[6] Scientia Clin Res, Randwick, NSW, Australia
[7] Duke Univ, Med Ctr, Durham, NC 27706 USA
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[10] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[11] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA
[12] Amgen Inc, Thousand Oaks, CA 91320 USA
[13] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 11期
关键词：
AMG; 510; lung cancer; KRAS G12C; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OA01.06
引用
收藏
页码：S1125 / S1126
页数：2
相关论文
共 50 条
  • [1] Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
    Zhang, Shannon S.
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 115 - 122
  • [2] Sotorasib: a KRASG12C inhibitor for non-small cell lung cancer
    Ganguly, Arghya
    Yoo, Euna
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (06) : 536 - 537
  • [3] Phase 1 Study of Safety, Tolerability, PK and Efficacy of AMG 510, a Novel KRASG12C Inhibitor, Evaluated in NSCLC
    Govindan, R.
    Fakih, M.
    Price, T.
    Falchook, G.
    Desai, J.
    Kuo, J.
    Strickler, J.
    Krauss, J.
    Li, B.
    Denlinger, C.
    Durm, G.
    Ngang, J.
    Henary, H.
    Ngarmchamnanrith, G.
    Rasmussen, E.
    Morrow, P.
    Hong, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S208 - S208
  • [4] Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer
    Blaquier, Juan Bautista
    Cardona, Andres Felipe
    Recondo, Gonzalo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Evaluation of KRASG12C inhibitor responses in novel murine KRASG12C lung cancer cell line models
    Sisler, Daniel J.
    Hinz, Trista K.
    Le, Anh T.
    Kleczko, Emily K.
    Nemenoff, Raphael A.
    Heasley, Lynn E.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] KRASG12C G12C Inhibitors in Non-Small Cell Lung Cancer: A Review
    Tang, Min
    Wu, Yijun
    Bai, Xiufeng
    Lu, You
    ONCOTARGETS AND THERAPY, 2024, 17 : 683 - 695
  • [7] Virtual clinical trial simulations for a novel KRASG12C inhibitor (ASP2453) in non-small cell lung cancer
    Sayama, Hiroyuki
    Marcantonio, Diana
    Nagashima, Takeyuki
    Shimazaki, Masashi
    Minematsu, Tsuyoshi
    Apgar, Joshua F.
    Burke, John M.
    Wille, Lucia
    Nagasaka, Yasuhisa
    Kirouac, Daniel C.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (08): : 864 - 877
  • [8] Activity and resistance to KRASG12C G12C inhibitors in non-small cell lung cancer and colorectal cancer
    Ye, Wei
    Lu, Xin
    Qiao, Yue
    Ou, Wen-Bin
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (03):
  • [9] Adagrasib: a novel inhibitor for KRASG12C-mutated non-small-cell lung cancer
    Guo, Matthew Z.
    Marrone, Kristen A.
    Spira, Alexander
    Rosner, Samuel
    FUTURE ONCOLOGY, 2023, 19 (15) : 1037 - 1051
  • [10] Targeting USP47 enhances the efficacy of KRAS inhibitor in KRASG12C mutated non-small cell lung cancer by controlling deubiquitination of c-Myc
    Shin, Hyungkyung
    Hwang, Sua
    Jeong, Jeong Hyun
    Shin, Sang Chul
    Oh, Yeonji
    Kim, Jinhyeok
    Hwang, Inah
    Kim, Eunice EunKyeong
    Choo, Hyunah
    Song, Eun Joo
    PHARMACOLOGICAL RESEARCH, 2025, 215
12345